摘要
目的评价鼻内镜下经筛窦及眶内壁减压联合眶脂肪减压治疗甲状腺相关性眼病(TAO)的效果。方法回顾性分析TAO11例(17眼)的临床资料。患者均为眼球突出非组织活动期,内镜下行经筛窦及眶内壁眶减压联合脂肪减压手术,术后定期随访。结果术后6个月,眼球突出矫正度达(5.24±1.79)mm,与术前比较差异有统计学意义(P〈0.05),且术后双眼眼球突出度相差均〈2mm;术前角膜上皮异常者14眼(82.35%),术后减少为2眼(11.76%),差异有统计学意义(P〈0.05);术后睑裂高度平均下降(2.59±0.48)mm,与术前比较差异有统计学意义(P〈0.05)。术后无视力下降或眶内出血等并发症发生。结论鼻内镜下眶内壁减压联合眶脂肪减压术治疗甲状腺相关性眼病效果良好。
Objective To evaluate the efficacy of endoscopic transethmoid and orbital medial wall decompression combined with orbital fat decompression for thyroid associated ophthalmopathy (TAO). Methods The data of 17 eyes of 11 patients with TAO were selected and retrospectively analyzed. They reeeieved endoscopic transethmoid and orbital medial wall decompression combined with orbital fat decompression. All patients were followed up periodically. Results Six months after surgery, the mean reduction in proptosis was ( 5.24 +- 1.79 ) ram, the difference was statistically significant between before and after surgery ( P 〈 0.05 ). Postoperatively the difference of exophthalmos between the both eyes was within 2 mm. Corneal epithelial abnormalities decreesed from 14 eyes (82. 35% ) preoperative to 2 eyes (11.76%) postperative , the difference was statistically significant (P 〈 0. 05 ). And postoperative mean height of palpebral fissure decreased ( 2.59 ± 0.48 ) mm, the difference was statistically significant ( P 〈 0.05). There was no loss of visual acuity, orbital bleeding or other complication. Conclusion The endoscopic transethmoid orbital medial wall decompression combined with orbital fat decompression is an effective treatment for TAO.
出处
《中华眼外伤职业眼病杂志》
2017年第11期840-842,共3页
Chinese Journal of Ocular Trauma and Occupational Eye Disease
关键词
眼病
甲状腺相关性
眶减压术
经筛窦
内窥镜下
Ophthalmopathy, thyroid associated
Orbital decompression, transethmoid medical wall, endoscopic